NICE TRY FarmaZutical...you are late to the party and without adequate DD...
The U.S. Regional Bio-Containment Laboratory (at Rutgers) sought out IPIX for the Brilacidin testing...and continues to do so at not cost to IPIX...and is rumored to expand its efforts to go beyond Covid-19 virus...to other viruses (at not cost to IPIX), as a therapeutic... against these viruses with no effective therapeutic...AND THESE SCIENTISTS ARE EAGER TO PUBLISH THEIR PEER REVIEW ARTICLE ...AT NO COST TO IPIX...as well as having made an Co-GRANT APPLICATION...at no cost to IPIX
Of course everyone knows that...but you! And they also know the Human Tissue Tests Results at the RBL (Rutgers):
"Brilacidin exhibited a statistically significant (p<0.0001) and potent inhibitory effect on SARS-CoV-2, the novel coronavirus responsible for COVID-19, in a human lung epithelial cell line—reducing viral load by 95 percent and by 97 percent, compared to control, at two therapeutic concentrations tested. Based on a CC50 value—the concentration of drug at which 50 percent of cells maintain viability—Brilacidin was also shown to be non-cytotoxic in the lung cell line."
ALSO...
AFTER BEING SAUGHT OUT AND CONTACTED....by George Mason University Laboratory...a designated leading Public Health Research Institute (PHRI) testing Brilacidin on Human Tissue Line...demonstated that it inhibits SARS-CoV-2, the novel coronavirus responsible for COVID-19, in a human cell line.
"Brilacidin, in comparison to vehicle control, exhibited an inhibitory effect on SARS-CoV-2 in a dose-dependent manner—an average 29 percent inhibition at 0.1ug/ml (the lowest concentration) to an 85 percent inhibition at 100ug/ml (the highest concentration)."
AND THESE SCIENTISTS... are ALSO EAGER TO PUBLISH THEIR PEER REVIEW ARTICLE ...AT NO COST TO IPIX.
...BOTH LABORATORIES are with BSL-3 testing capabilities.
...BOTH sought out IPIX and BRILACIDIN for testing and did tests...and
...BOTH were free!...
The $35K IPIX "offered" to pay for additional testing (to cover nominal costs) were beyond the parameters of the completed tests...but will give IPIX ADDITIONAL DATA for "Future" Grant and FDA Applications (More DATA is ALWAYS BETTER!) and support FDA application for Human Trials on COVID-19 and possible BEYOND (Ebola, Mers etc)...
WHY, would LEO not take them up on the offer to do additional test, for additional supportive DATA...so that FDA would not review and ask for it anyway?
FARMAZ...you will just have to buy here...your success in knocking down IPIX and Brilacidin...WILL FAIL MISERABLY!
...not even a credible effort ...try pouncing on a BS candidate...not BRILACIDIN...
News 
Market Data 
Discover 
